These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1519478)
1. Antibodies to Borrelia burgdorferi in patients with carpal tunnel syndrome. Kindstrand E Acta Neurol Scand; 1992 Jul; 86(1):73-5. PubMed ID: 1519478 [TBL] [Abstract][Full Text] [Related]
2. Comparison of flagellum and sonicate antigens for serological diagnosis of Lyme borreliosis. Karlsson M; Stiernstedt G; Granström M; Asbrink E; Wretlind B Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):169-77. PubMed ID: 2186910 [TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918 [TBL] [Abstract][Full Text] [Related]
4. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans. Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835 [TBL] [Abstract][Full Text] [Related]
5. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species. Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807 [TBL] [Abstract][Full Text] [Related]
8. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. Hammers-Berggren S; Lebech AM; Karlsson M; Svenungsson B; Hansen K; Stiernstedt G J Clin Microbiol; 1994 Jun; 32(6):1519-25. PubMed ID: 8077398 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis]. Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336 [TBL] [Abstract][Full Text] [Related]
11. Procalcitonin levels in patients with Lyme borreliosis. Lotric-Furlan S; Maraspin-Carman V; Cimperman J; Ogrinc K; Stopar T; Strle F Wien Klin Wochenschr; 2002 Jul; 114(13-14):530-2. PubMed ID: 12422595 [TBL] [Abstract][Full Text] [Related]
12. Changes in Borrelia burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans. Olsson I; Asbrink E; von Stedingk M; von Stedingk LV Acta Derm Venereol; 1994 Nov; 74(6):424-8. PubMed ID: 7701871 [TBL] [Abstract][Full Text] [Related]
13. [Lymphocyte proliferation test in cutaneous manifestations of Lyme borreliosis]. Breier F; Klade H; Stanek G Wien Med Wochenschr; 1995; 145(7-8):170-3. PubMed ID: 7610666 [TBL] [Abstract][Full Text] [Related]
14. Current perspective on Lyme borreliosis. Kaslow RA JAMA; 1992 Mar; 267(10):1381-3. PubMed ID: 1740862 [No Abstract] [Full Text] [Related]
15. Serological follow-up after treatment of Borrelia arthritis and acrodermatitis chronica atrophicans. Hammers-Berggren S; Lebech AM; Karlsson M; Andersson U; Hansen K; Stiernstedt G Scand J Infect Dis; 1994; 26(3):339-47. PubMed ID: 7939435 [TBL] [Abstract][Full Text] [Related]